Adora Ndu - Oct 12, 2022 Form 3 Insider Report for ACADIA PHARMACEUTICALS INC (ACAD)

Role
Director
Signature
/s/ Austin D. Kim, Attorney-in-Fact
Stock symbol
ACAD
Transactions as of
Oct 12, 2022
Transactions value $
$0
Form type
3
Date filed
10/14/2022, 06:53 PM
Previous filing
Jun 11, 2021
Next filing
Jun 5, 2023

No securities are beneficially owned.